Clinical trial / 1986
Intravenous amino acid loading significantly reduced brain uptake of L-[18F]fluorodopa in a healthy human subject.
Brain uptake of L-[18F]fluorodopa was measured using positron emission tomography in one healthy male volunteer under fasting conditions and during intravenous amino acid loading. A significant reduction of tracer uptake into the brain was demonstrated during amino acid loading. This provides in vivo human evidence for competition between L-dopa and other amino acids across the blood-brain barrier.
- Study type
- Interventional crossover case study
- Who was studied
- 1 healthy male volunteer
- What was measured
- Brain uptake of L-[18F]fluorodopa measured by PET
THE PAPER
Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.
Leenders KL, Poewe WH, Palmer AJ, Brenton DP, Frackowiak RS. Ann Neurol, 1986.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.